BG60852B1 - Нитроглицерин, съдържащ хидрофилен, воден спрей с помпа - Google Patents
Нитроглицерин, съдържащ хидрофилен, воден спрей с помпа Download PDFInfo
- Publication number
- BG60852B1 BG60852B1 BG94775A BG9477591A BG60852B1 BG 60852 B1 BG60852 B1 BG 60852B1 BG 94775 A BG94775 A BG 94775A BG 9477591 A BG9477591 A BG 9477591A BG 60852 B1 BG60852 B1 BG 60852B1
- Authority
- BG
- Bulgaria
- Prior art keywords
- nitroglycerin
- spray
- ethanol
- pump
- propylene glycol
- Prior art date
Links
- 239000007921 spray Substances 0.000 title claims abstract description 49
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 title claims description 48
- 239000000006 Nitroglycerin Substances 0.000 title claims description 24
- 229960003711 glyceryl trinitrate Drugs 0.000 title claims description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 46
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 25
- 229960004063 propylene glycol Drugs 0.000 claims description 20
- 239000008213 purified water Substances 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 5
- 238000009516 primary packaging Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 239000012159 carrier gas Substances 0.000 abstract description 9
- 238000003860 storage Methods 0.000 abstract description 4
- 239000000243 solution Substances 0.000 description 22
- 238000009472 formulation Methods 0.000 description 11
- 239000000443 aerosol Substances 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- 239000013543 active substance Substances 0.000 description 9
- 239000004480 active ingredient Substances 0.000 description 8
- 239000002552 dosage form Substances 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 239000011521 glass Substances 0.000 description 6
- 206010002383 Angina Pectoris Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 239000006190 sub-lingual tablet Substances 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 4
- 210000004877 mucosa Anatomy 0.000 description 4
- 235000013772 propylene glycol Nutrition 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 230000009471 action Effects 0.000 description 2
- -1 aliphatic alcohols Chemical class 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 229920001515 polyalkylene glycol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000011990 functional testing Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 239000000346 nonvolatile oil Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 229940098466 sublingual tablet Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Physiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4026072A DE4026072A1 (de) | 1990-08-17 | 1990-08-17 | Nitroglycerinhaltiger, hydrophiler, waessriger pumpspray |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BG94775A BG94775A (bg) | 1993-12-24 |
| BG60852B1 true BG60852B1 (bg) | 1996-05-31 |
Family
ID=6412426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG94775A BG60852B1 (bg) | 1990-08-17 | 1991-07-08 | Нитроглицерин, съдържащ хидрофилен, воден спрей с помпа |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5744124A (pt) |
| EP (1) | EP0471161B1 (pt) |
| JP (1) | JPH0818981B2 (pt) |
| AT (1) | ATE110567T1 (pt) |
| BG (1) | BG60852B1 (pt) |
| CZ (1) | CZ280490B6 (pt) |
| DE (1) | DE4026072A1 (pt) |
| DK (1) | DK0471161T3 (pt) |
| ES (1) | ES2060248T3 (pt) |
| FI (1) | FI102873B (pt) |
| HR (1) | HRP920988B1 (pt) |
| HU (1) | HU206615B (pt) |
| IE (1) | IE65273B1 (pt) |
| PT (1) | PT98658B (pt) |
| RU (1) | RU2060733C1 (pt) |
| SI (1) | SI9111215A (pt) |
| SK (1) | SK279132B6 (pt) |
| YU (1) | YU48633B (pt) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030190286A1 (en) * | 1997-10-01 | 2003-10-09 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma |
| EP1036561A1 (en) | 1997-10-01 | 2000-09-20 | Flemington Pharmaceutical Corporation | Buccal, non-polar spray |
| US20030077227A1 (en) | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| US20030185761A1 (en) | 1997-10-01 | 2003-10-02 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
| US20030095925A1 (en) * | 1997-10-01 | 2003-05-22 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders |
| US7632517B2 (en) | 1997-10-01 | 2009-12-15 | Novadel Pharma Inc. | Buccal, polar and non-polar spray containing zolpidem |
| US20040136914A1 (en) | 1997-10-01 | 2004-07-15 | Dugger Harry A. | Buccal, polar and non-polar spray containing ondansetron |
| US20030072717A1 (en) * | 2001-02-23 | 2003-04-17 | Vapotronics, Inc. | Inhalation device having an optimized air flow path |
| EP1389137B1 (en) * | 2001-05-21 | 2006-07-19 | InJet Digital Aerosols Limited | Compositions for protein delivery via the pulmonary route |
| GB0417675D0 (en) * | 2004-08-09 | 2004-09-08 | Futura Medical Dev Ltd | Composition for promoting vascular smooth muscle relaxation |
| GB0602224D0 (en) * | 2006-02-03 | 2006-03-15 | Futura Medical Dev Ltd | Composition for promoting vascular smooth muscle relaxation |
| DE202008007318U1 (de) | 2008-03-14 | 2008-07-31 | G. Pohl-Boskamp Gmbh & Co. Kg | Langzeitstabile pharmazeutische Zubereitung mit dem Wirkstoff Glyceroltrinitrat |
| US20100184870A1 (en) * | 2008-03-14 | 2010-07-22 | Rolf Groteluschen | Long-term stable pharmaceutical preparation containing the active ingredient glycerol trinitrate |
| EP2990032A1 (en) | 2010-08-03 | 2016-03-02 | G. Pohl-Boskamp GmbH & Co. KG | Use of glyceryl trinitrate for treating traumatic edema |
| EP2678000B1 (en) | 2011-02-25 | 2018-03-07 | G. Pohl-Boskamp GmbH & Co. KG | Stabilized granules containing glyceryl trinitrate |
| US9248099B2 (en) | 2012-05-31 | 2016-02-02 | Desmoid Aktiengesellschaft | Use of stabilized granules containing glyceryl trinitrate for arteriogenesis |
| ES2617494T3 (es) | 2012-05-31 | 2017-06-19 | G. Pohl-Boskamp Gmbh & Co. Kg | Inducción de arteriogénesis con un donador de óxido nítrico tal como nitroglicerina |
| EP2878310B1 (en) | 2013-11-29 | 2017-01-11 | G. Pohl-Boskamp GmbH & Co. KG | Sprayable aqueous composition comprising glyceryl trinitrate |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE632504A (pt) * | 1962-05-24 | |||
| JPS599539B2 (ja) * | 1979-11-13 | 1984-03-03 | 日本化薬株式会社 | ニトログリセリン水溶液及びその製造法 |
| DE3246081A1 (de) * | 1982-12-13 | 1984-06-14 | G. Pohl-Boskamp GmbH & Co Chemisch-pharmazeutische Fabrik, 2214 Hohenlockstedt | Nitroglycerin-spray |
| DE3613187A1 (de) * | 1986-04-18 | 1987-10-22 | Mack Chem Pharm | Verwendung einer carbonsaeure in zur topischen anwendung bestimmten pharmazeutischen zubereitungen |
| JPH0645538B2 (ja) * | 1987-09-30 | 1994-06-15 | 日本化薬株式会社 | ニトログリセリンスプレー剤 |
| HU199678B (en) * | 1988-07-08 | 1990-03-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing aerosols containing nitroglicerol |
| DE4018919C2 (de) * | 1990-06-13 | 1994-08-25 | Sanol Arznei Schwarz Gmbh | Nitroglycerin-Spray |
-
1990
- 1990-08-17 DE DE4026072A patent/DE4026072A1/de active Granted
-
1991
- 1991-06-12 ES ES91109613T patent/ES2060248T3/es not_active Expired - Lifetime
- 1991-06-12 AT AT91109613T patent/ATE110567T1/de not_active IP Right Cessation
- 1991-06-12 EP EP91109613A patent/EP0471161B1/de not_active Expired - Lifetime
- 1991-06-12 DK DK91109613.9T patent/DK0471161T3/da active
- 1991-07-08 SK SK2099-91A patent/SK279132B6/sk unknown
- 1991-07-08 BG BG94775A patent/BG60852B1/bg unknown
- 1991-07-08 CZ CS912099A patent/CZ280490B6/cs not_active IP Right Cessation
- 1991-07-08 HU HU912300A patent/HU206615B/hu not_active IP Right Cessation
- 1991-07-10 YU YU121591A patent/YU48633B/sh unknown
- 1991-07-10 SI SI9111215A patent/SI9111215A/sl unknown
- 1991-07-17 IE IE250991A patent/IE65273B1/en not_active IP Right Cessation
- 1991-08-13 PT PT98658A patent/PT98658B/pt active IP Right Grant
- 1991-08-15 RU SU915001270A patent/RU2060733C1/ru active
- 1991-08-16 JP JP3205337A patent/JPH0818981B2/ja not_active Expired - Lifetime
- 1991-08-16 FI FI913882A patent/FI102873B/fi active
-
1992
- 1992-05-26 US US07/890,314 patent/US5744124A/en not_active Expired - Fee Related
- 1992-10-02 HR HRP-1215/91A patent/HRP920988B1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0818981B2 (ja) | 1996-02-28 |
| IE912509A1 (en) | 1992-02-26 |
| IE65273B1 (en) | 1995-10-18 |
| FI913882A (fi) | 1992-02-18 |
| HU206615B (en) | 1992-12-28 |
| PT98658B (pt) | 1999-01-29 |
| CS209991A3 (en) | 1992-02-19 |
| HRP920988B1 (en) | 1998-10-31 |
| ES2060248T3 (es) | 1994-11-16 |
| FI102873B1 (fi) | 1999-03-15 |
| EP0471161B1 (de) | 1994-08-31 |
| HRP920988A2 (en) | 1996-10-31 |
| BG94775A (bg) | 1993-12-24 |
| DE4026072A1 (de) | 1992-02-20 |
| YU121591A (sh) | 1994-01-20 |
| EP0471161A1 (de) | 1992-02-19 |
| FI913882A0 (fi) | 1991-08-16 |
| SK279132B6 (sk) | 1998-07-08 |
| HUT59308A (en) | 1992-05-28 |
| PT98658A (pt) | 1992-06-30 |
| YU48633B (sh) | 1999-03-04 |
| DK0471161T3 (da) | 1994-10-03 |
| HU912300D0 (en) | 1991-12-30 |
| RU2060733C1 (ru) | 1996-05-27 |
| ATE110567T1 (de) | 1994-09-15 |
| US5744124A (en) | 1998-04-28 |
| DE4026072C2 (pt) | 1992-05-21 |
| JPH04230627A (ja) | 1992-08-19 |
| SI9111215A (en) | 1995-08-31 |
| CZ280490B6 (cs) | 1996-01-17 |
| FI102873B (fi) | 1999-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG60852B1 (bg) | Нитроглицерин, съдържащ хидрофилен, воден спрей с помпа | |
| US9937202B2 (en) | Topical nitric oxide systems and methods of use thereof | |
| IE68451B1 (en) | Nitroglycerin pump spray | |
| MXPA02003312A (es) | Composiciones que tienen estabilidad mejorada. | |
| JPH0651620B2 (ja) | ニトログリセリンを含む噴射ガス不使用のエアロゾル組成物、およびその製造方法 | |
| EP2498771A1 (en) | Use of bethanechol for treatment of xerostomia | |
| JPS62242618A (ja) | 水銀含有防腐剤を安定化した眼炎治療薬 | |
| HU192246B (en) | Process for producing of galenic compositions consisting of calcitonin | |
| RU2456984C2 (ru) | Галеновая форма для чресслизистого введения парацетамола | |
| JP2624396B2 (ja) | ニトログリセリンエアゾールスプレー | |
| JP2017137304A (ja) | ロキソプロフェンを含有する医薬製剤 | |
| AU2004246961B2 (en) | Transnasal microemulsions containing diazepam | |
| JP2017197537A (ja) | ロキソプロフェン含む医薬の製剤 | |
| JP3533228B2 (ja) | 低刺激性ニトログリセリン組成物及びスプレー剤 | |
| WO2005007070A2 (en) | Stable pharmaceutical composition | |
| US7632853B2 (en) | Soluble, stable and concentrated pharmaceutical composition compromising ritonavir and process for preparing thereof | |
| JPH044300B2 (pt) | ||
| FR2622800A1 (fr) | Procede de preparation d'un produit de lutte contre des affections virales en particulier des affections virales cutaneo-muqueuses,compositions pharmaceutiques et medicaments obtenus a partir de ce procede | |
| KR20010072412A (ko) | 경피 투여용 아스피린 | |
| US20060217320A1 (en) | Soft gel formulations for saquinavir | |
| MXPA01007020A (en) | Compositions having improved stability |